LPL Financial’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$787K Buy
170,263
+10,563
+7% +$40K ﹤0.01% 4628
2026
Q1
$462K Buy
159,700
+94,575
+145% +$202K ﹤0.01% 4833
2025
Q4
$105K Buy
65,125
+41,967
+181% +$66K ﹤0.01% 5585
2025
Q3
$38.9K Buy
23,158
+2,000
+9% +$3.24K ﹤0.01% 5665
2025
Q2
$25.6K Hold
21,158
﹤0.01% 5438
2025
Q1
$26.9K Hold
21,158
﹤0.01% 5224
2024
Q4
$68.8K Sell
21,158
-8,500
-29% -$30.6K ﹤0.01% 5069
2024
Q3
$97.6K Sell
29,658
-800
-3% -$3.12K ﹤0.01% 4897
2024
Q2
$129K Buy
30,458
+19,475
+177% +$190K ﹤0.01% 4683
2024
Q1
$162K Buy
+10,983
New +$166K ﹤0.01% 4550

Other funds holding MGNX

LPL Financial's MGNX Position: Q2 2026 in Review

LPL Financial increased its MacroGenics (MGNX) stake by 6.6% in Q2 2026, buying an estimated $40K and bringing the position to 170,263 shares worth $787K. The position accounts for ﹤0.01% of the portfolio, ranked #4628.

LPL Financial first reported a position in MGNX in Q1 2024 and has held it in 10 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • LPL Financial held 170,263 shares of MacroGenics worth $787K as of Q2 2026.
  • LPL Financial bought 10,563 MacroGenics shares in Q2 2026, an estimated $40K.
  • MacroGenics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4628 holding.
  • LPL Financial first reported a position in MacroGenics in Q1 2024 and has held it in 10 quarters since.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.